Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 2.022
Filtrer
1.
Article de Chinois | MEDLINE | ID: mdl-38973047

RÉSUMÉ

Objective:To explore efficacy of narrow band imaging(NBI) technique in CO2laser therapy in Early-Stage Glottic cancer. Methods:The clinical data of patients with Early-Stage Glottic cancer who underwent CO2laser vocal cord resection from June 2011 to August 2022 were retrospectively analyzed. Among these, 27 patients who underwent surgery assisted by NBI were assigned to the observation group, while 25 patients who underwent conventional CO2 laser microsurgery with a suspension laryngoscope were assigned to the control group. The differences between the two groups were analyzed in terms of intraoperative frozen pathology results, postoperative recurrence rates, 5-year cumulative disease-free survival rates, complications, and voice recovery. Results:All 52 patients were operated successfully. Temporary tracheostomy and serious complications did not occur during the operation. The postoperative patient's pronunciation was satisfactory. One patient experienced vocal cord adhesion, but there were no severe complications such as breathing difficulties or bleeding, with an overall complication rate of 1.92%. Postoperative follow-up was 1-5 years. The 5 years recurrence free survival in the general group was 77.90%, and the 5 years recurrence free survival in the NBI group was 100%, the difference was statistically significant(P<0.05). NBI endoscopy is safer and more accurate than the general group in determining the safe margin of tumor mucosal resection(P<0.05). Among the patients who accepted the voice analysis, the difference was no statistically significant(P>0.05). Conclusion:Compared with conventional CO2laser surgery under microscope, NBI guided laser resection of Early-Stage Glottic cancer is more accurate. NBI guided laser resection could improve 5 years recurrence free survival rate. In a word, narrow-band imaging endoscopy can has very high value in clinical application.


Sujet(s)
Glotte , Tumeurs du larynx , Thérapie laser , Lasers à gaz , Imagerie à bande étroite , Humains , Tumeurs du larynx/chirurgie , Tumeurs du larynx/imagerie diagnostique , Tumeurs du larynx/anatomopathologie , Lasers à gaz/usage thérapeutique , Études rétrospectives , Imagerie à bande étroite/méthodes , Mâle , Femelle , Thérapie laser/méthodes , Adulte d'âge moyen , Plis vocaux/imagerie diagnostique , Laryngoscopie/méthodes , Microchirurgie/méthodes , Résultat thérapeutique , Récidive tumorale locale , Survie sans rechute , Stadification tumorale , Sujet âgé
2.
Lasers Med Sci ; 39(1): 160, 2024 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-38902432

RÉSUMÉ

This review aims to assess the efficacy and safety of laser therapy in managing scars resulting from cleft lip and/or palate (CL/P) repair surgeries, as well as to determine the optimal timing for intervention. A systematic search was conducted across four databases using a predefined search strategy. Studies included were randomized controlled trials, non-randomized studies, and case series focusing on laser therapy for CL/P scars. Data extraction and analysis were performed using Revman Software. A total of two randomized controlled trials, four non-randomized studies, and three case series were included in the analysis. The fractional CO2 laser was the most commonly utilized type of laser. Following laser therapy, there was a significant decrease in Vancouver Scar Scale (VSS) scores by 4.05 (95% CI, 2.10-5.99). Meta-analysis revealed that laser treatment groups exhibited a significantly lower mean VSS score (1.3; 95% CI, 0.02-2.67) compared to control groups. Moreover, initiating laser therapy intervention at one month postoperatively resulted in a significantly lower VSS score compared to initiation at three months postoperatively (difference of 1.70; 95% CI, 1.33-2.08). No severe complications were reported. Laser therapy demonstrates effectiveness and safety in improving CL/P scars, with earlier intervention yielding greater benefits.


Sujet(s)
Cicatrice , Bec-de-lièvre , Fente palatine , Humains , Cicatrice/étiologie , Cicatrice/radiothérapie , Bec-de-lièvre/chirurgie , Fente palatine/chirurgie , Thérapie laser/méthodes , Thérapie laser/effets indésirables , Lasers à gaz/usage thérapeutique , Photothérapie de faible intensité/méthodes , Résultat thérapeutique
3.
Arch Dermatol Res ; 316(7): 424, 2024 Jun 21.
Article de Anglais | MEDLINE | ID: mdl-38904687

RÉSUMÉ

Acanthosis nigricans (AN), with an estimated prevalence of 19.4% in the U.S., presents as hyperpigmented, velvety plaques in intertriginous regions. Acanthosis Nigricans negatively affects psychological well-being and particularly impacts skin of color individuals. Addressing the underlying cause of acanthosis nigricans, as current guidelines recommend, is often challenging. This highlights the importance of skin directed treatment for acanthosis nigricans. This systematic review evaluated topical, laser, and oral treatments for acanthosis nigricans and provides evidence-based recommendations for clinical use. Adhering to PRISMA guidelines, we evaluated 19 clinical trials investigating topical, oral, and laser interventions for acanthosis nigricans. Oxford Centre for Evidence-Based Medicine guidelines were used to make clinical recommendations. We strongly recommend topical tretinoin (grade A) and endorse the appropriate use of adapalene gel, urea cream, and fractional carbon dioxide laser therapy (grade B). Further research is essential to enhance our understanding of alternative treatments to determine additional evidence-based recommendations. This review aims to guide clinicians in managing acanthosis nigricans, especially when direct treatment of underlying conditions is impractical.


Sujet(s)
Acanthosis nigricans , Humains , Acanthosis nigricans/diagnostic , Acanthosis nigricans/traitement médicamenteux , Administration par voie orale , Thérapie laser/méthodes , Essais cliniques comme sujet , Administration par voie cutanée , Médecine factuelle , Produits dermatologiques/administration et posologie , Produits dermatologiques/usage thérapeutique , Administration par voie topique , Lasers à gaz/usage thérapeutique , Trétinoïne/administration et posologie , Trétinoïne/usage thérapeutique , Résultat thérapeutique
4.
Arch Esp Urol ; 77(4): 385-390, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38840281

RÉSUMÉ

BACKGROUND: Urinary incontinence is common in patients with genitourinary syndrome of menopause (GSM). A retrospective cohort study was conducted to analyse the clinical efficacy of carbon dioxide laser combined with pelvic floor functional exercise for GSM with urinary incontinence, aiming to provide evidence for its clinical treatment. METHODS: Patients diagnosed with GSM and urinary incontinence and admitted to our hospital from January 2021 to December 2022 were included and allocated to a control group (pelvic floor function exercise) and combined group (carbon dioxide laser combined with pelvic floor function exercise). Confounding factors among the groups were balanced by the propensity score matching method. The clinical efficacy, GSM scale scores, urinary indicators, urinary incontinence quality of life scale (I-QOL) scores and the degree of urinary incontinence of the groups were compared. RESULTS: A total of 192 patients were included in this study, and 36 cases were included in each group after the propensity scores were matched. No statistical difference in baseline data was found between the groups (p > 0.05). The combined group had higher total effective rate and I-QOL scores but lower GSM symptom scale scores than the control group. Urination during daytime and nighttime was less frequent in the combined group than in the control group, which showed a lower degree of urinary incontinence (p < 0.05). CONCLUSIONS: Combining carbon dioxide laser treatment with pelvic floor exercises is potentially effective for patients with GSM and urinary incontinence. This combined approach not only alleviated GSM and urinary incontinence symptoms but also reduced the severity of urinary incontinence, promoted bladder function recovery and enhanced overall quality of life.


Sujet(s)
Traitement par les exercices physiques , Lasers à gaz , Plancher pelvien , Incontinence urinaire , Humains , Femelle , Incontinence urinaire/étiologie , Incontinence urinaire/thérapie , Études rétrospectives , Adulte d'âge moyen , Traitement par les exercices physiques/méthodes , Lasers à gaz/usage thérapeutique , Syndrome , Ménopause , Association thérapeutique , Maladies urogénitales de la femme/complications , Résultat thérapeutique , Études de cohortes
5.
J Int Med Res ; 52(6): 3000605241253759, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38853406

RÉSUMÉ

Treatment of lower limb ischemia in patients with diabetes is challenging because of the location of the ulcers and the complexity of their pathogenesis. Carbon dioxide fractional laser (CO2FL) therapy in conjunction with tibial periosteum distraction could become a substitute for conventional methods. We herein describe a patient diagnosed with ischemic diabetic foot with a complex ulcer in the upper third of the tibia. Laser irradiation (Deep FX mode with 30 mJ of energy and 10% density) was applied to the entire region of skin below the knee after surface anesthesia, and this treatment was performed twice a week until the ulcer healed. Computed tomography angiography showed successful establishment of a blood supply to the back of the right foot after treatment. Skin grafting was successfully performed, with only a few wounds remaining on the foot 8 months after treatment. The pain score was significantly decreased at the last follow-up. No complications occurred. This case report provides guidance for the performance of CO2FL, a fast, easy, accurate treatment in patients with diabetes. CO2FL can target lower limb arterial occlusive disease accompanied by refractory ulcers, addressing the underlying vascular occlusion and dysfunction as well as promoting microcirculation and wound healing.


Sujet(s)
Pied diabétique , Ischémie , Lasers à gaz , Membre inférieur , Humains , Pied diabétique/thérapie , Pied diabétique/chirurgie , Lasers à gaz/usage thérapeutique , Ischémie/étiologie , Ischémie/thérapie , Mâle , Membre inférieur/vascularisation , Sujet âgé , Adulte d'âge moyen , Cicatrisation de plaie , Résultat thérapeutique
6.
Lasers Med Sci ; 39(1): 159, 2024 Jun 19.
Article de Anglais | MEDLINE | ID: mdl-38890186

RÉSUMÉ

Striae distensae are common dermatological complaint. Cold laser using low-level light/laser therapy (LLLT) offers healing and analgesic effects and was not yet compared to 'hot lasers' efficacy. Study objective: to assess the efficacy and safety of LLLT in the management of stria alba compared to fractional carbon dioxide (FCO2) laser alone and to the combined use of both devices. Thirty patients with stria alba were randomized to receive either LLLT using diode 808 nm; 8-12 sessions, 2-3 sessions weekly (Group A) or FCO2 laser; 2 monthly sessions (Group B) or combined both devices simultaneously (Group C). Follow up was at 1 month and 3 months after last session. The efficacy of LLLT was statistically comparable to FCO2, despite numerical superiority of the latter. The combined group had the least numerical values in all efficacy outcomes. Patients in LLLT group did not experience any downtime. LLLT is effective in the management of stria alba comparable to the FCO2 laser. The lack of downtime with LLLT is reflected positively on patient's satisfaction. However, this is counterbalanced by the frequent weekly visits. Although adding LLLT to FCO2 laser palliates the laser side effects but it offers the least efficacy. Trial registration number NCT04165226 (clinicaltrials.gov).


Sujet(s)
Lasers à gaz , Photothérapie de faible intensité , Humains , Lasers à gaz/usage thérapeutique , Adulte , Femelle , Photothérapie de faible intensité/méthodes , Photothérapie de faible intensité/instrumentation , Mâle , Adulte d'âge moyen , Jeune adulte , Résultat thérapeutique , Satisfaction des patients , Adolescent
7.
Photobiomodul Photomed Laser Surg ; 42(6): 414-421, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38888192

RÉSUMÉ

Objectives: This study aimed to evaluate the vagina clinically, cytologically, and histologically before and after treating genitourinary syndrome of menopause (GSM) with fractional microablative carbon dioxide LASER (CO2L), radiofrequency (RF), and estrogen vaginal cream (CT). Methods: Women with moderate-to-severe symptoms of GSM, denoted by a GSM Visual analog scale (VAS) score of >4, were eligible for this study. The patients were randomized into treatment groups. In the energy groups, three vulvovaginal applications were administered monthly. The CT group used 0.5 mg vaginal estriol cream for 14 consecutive days, followed by twice a week for 4 months. The follow-up visits occurred 120 days after the beginning of the treatments. The same parameters obtained at the first visit were re-evaluated: GSM VAS score, Incontinence Quality of Life Questionnaire (I-QOL), gynecological examination determining Vaginal Health Index (VHI), vaginal smear for Vaginal Maturation Value (VMV), and vaginal biopsy. Results: Seventy-one women were included, 48 completed the study and provided adequate samples for analysis (CO2L [21 patients], RF [15 patients], and CT [12 patients]). GSM symptoms, I-QOL, and VHI significantly improved after all proposed treatments, with no significant differences between them. VMV did not change after any treatment; however, only 22.9% of the patients presented with cytological atrophy before treatment. Histological vaginal atrophy was identified in 6 (12.5%) pretreated vaginal samples. After the intervention, all histological parameters were normalized, no tissue damage was observed, and no major clinical complications were observed. Conclusion: CO2L and RF seem to be good alternatives to CT for GSM treatment, with no tissue damage.


Sujet(s)
Lasers à gaz , Ménopause , Vagin , Humains , Femelle , Lasers à gaz/usage thérapeutique , Adulte d'âge moyen , Vagin/effets des radiations , Syndrome , Maladies urogénitales de la femme/thérapie , Qualité de vie , Crèmes, mousses et gels vaginaux/usage thérapeutique , Sujet âgé
8.
Arch Dermatol Res ; 316(6): 244, 2024 May 25.
Article de Anglais | MEDLINE | ID: mdl-38795247

RÉSUMÉ

Melanoma, accounting for a significant proportion of skin cancer-related deaths, has variable survival outcomes based on the stage at diagnosis and treatment efficacy. Traditional treatments, while effective, pose risks of scarring and systemic side effects. Laser therapy offers an emerging non-surgical alternative, with CO2 lasers particularly showing promise in palliative care.A comprehensive search was conducted using PubMed, focusing on laser therapy for melanoma treatment. The search included studies on both stand-alone and adjunct laser therapies, with inclusion criteria requiring peer-reviewed articles detailing treatment outcomes for primary, recurrent, or metastatic melanoma.The literature shows that laser therapy for melanoma falls into four major types when categorized by laser medium: solid-state, diode, pulse-dye, and gas (CO2). Data on solid-state lasers for melanoma are limited and their use remains controversial. However, one study with high-energy pulsed neodymium lasers reported a 5-year survival of 82.9% with minimal adverse effects for primary melanoma. CO2 laser therapy has been effective for palliative treatment, with one study showing 54.8% of patients with recurrent melanoma surviving 5.4 years post-ablation. For metastatic melanoma, numerous studies have shown that CO2 laser therapy can provide symptomatic relief and disease control. Combination therapies using lasers and immune-based therapies have demonstrated enhanced outcomes and immune activation, highlighting the potential of laser therapies in melanoma management.While traditional treatments remain the standard for primary melanoma, laser therapies, particularly CO2 laser ablation, show substantial promise in palliative care for metastatic melanoma. Careful patient selection and assessment are crucial for achieving positive outcomes.


Sujet(s)
Mélanome , Soins palliatifs , Tumeurs cutanées , Humains , Mélanome/thérapie , Mélanome/mortalité , Mélanome/chirurgie , Mélanome/radiothérapie , Tumeurs cutanées/chirurgie , Tumeurs cutanées/anatomopathologie , Tumeurs cutanées/thérapie , Soins palliatifs/méthodes , Résultat thérapeutique , Lasers à gaz/usage thérapeutique , Lasers à gaz/effets indésirables , Thérapie laser/méthodes , Thérapie laser/effets indésirables , Association thérapeutique , Lasers à solide/usage thérapeutique , Lasers à solide/effets indésirables , Récidive tumorale locale
9.
Maturitas ; 186: 108008, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38714422

RÉSUMÉ

OBJECTIVE: To compare the effects of fractional CO2 laser and microablative fractional radiofrequency treatment with promestriene topical estrogen on sexual function and genitourinary syndrome of menopause symptoms. METHODS: This was a prospective randomized open-label clinical trial conducted with 62 postmenopausal women assigned to three intervention groups: a) topical promestriene for 90 days (n = 17); b) fractional CO2 laser treatment (n = 24); and c) microablative fractional radiofrequency treatment (n = 21). Each of the latter two groups underwent three treatment sessions at 4-week intervals. At baseline and at the end of the study, all participants had a gynecological examination that included vaginal pH measurement, and the completion of the Vaginal Symptom Score, the Vaginal Health Index, and the Female Sexual Function Index. For the energy treatment groups, adverse effects were evaluated after each session. Group homogeneity was assessed at baseline, and results were evaluated over time (from baseline to the end of treatment) and between groups over time. RESULTS: All baseline parameters were similar among studied groups. At the end of the study, all 3 treatments had produced similar effects: a reduction of vaginal pH, and an improvement of vulvovaginal symptoms (Vaginal Symptom Score and Vaginal Health Index scores) as well as sexual function (higher total Female Sexual Function Index scores, and in the desire, arousal, lubrication and pain domain scores), with no differences observed between groups. Side-effects were slight for both energy treatment groups, mainly represented by vaginal discharge. CONCLUSION: The present study suggests that the two energy treatments were efficient along with promestriene at improving postmenopausal genitourinary and sexuality symptoms. Clinical trial identification numberNCT04717245.


Sujet(s)
Lasers à gaz , Vagin , Humains , Femelle , Adulte d'âge moyen , Lasers à gaz/usage thérapeutique , Études prospectives , Maladies urogénitales de la femme/thérapie , Syndrome , Ménopause , Oestrogènes/usage thérapeutique , Administration par voie vaginale , Concentration en ions d'hydrogène , Troubles sexuels d'origine physiologique/thérapie , Troubles sexuels d'origine physiologique/étiologie , Post-ménopause , Traitement par radiofréquence/méthodes , Dyspareunie/thérapie , Dyspareunie/étiologie , Sujet âgé , Oestradiol/analogues et dérivés
10.
Swiss Dent J ; 134(3)2024 May 17.
Article de Allemand | MEDLINE | ID: mdl-38757921

RÉSUMÉ

A pyogenic granuloma is an acquired, benign tissue formation of the skin and/or oral mucosa. Surgical excision is the most common treatment for these lesions. In this case report a case of a 60-year-old woman with a pyogenic granuloma in region 21 is presented. An excisional biopsy was performed with a CO2 laser under local anesthesia and the specimen was examined by a pathologist. No recurrency were observed in this case.


Sujet(s)
Granulome pyogénique , Humains , Femelle , Adulte d'âge moyen , Granulome pyogénique/chirurgie , Granulome pyogénique/anatomopathologie , Granulome pyogénique/diagnostic , Lasers à gaz/usage thérapeutique , Biopsie , Thérapie laser/méthodes , Diagnostic différentiel
11.
Swiss Dent J ; 134(1): 105-122, 2024 Feb 19.
Article de Allemand | MEDLINE | ID: mdl-38739046

RÉSUMÉ

A papilloma is a benign tumor arising from an epithelial surface. Mostly a papilloma appears as an asymptomatic intraoral lesion and is often associated with the human papilloma virus (HPV). In this case report two similar, verrucous papules, sessile bilateral on the back of the tongue, were surgically removed in a 65-year-old male patient. Thereby two different methods of treatment were compared. On the right side of the back of the tongue, excision by scalpel, as the gold standard treatment modality, was performed. On the left side a surgical removal by a CO2 laser was performed. In a photothermal procedure, without direct contact to the tissue, the laser beam is cutting through the mucosa. Secondary wound healing can take place. Both methods were compared in relation to their application, wound healing, quality of the biopsy and morbidity. Postoperative less discomfort and a slightly faster wound healing could be seen after scalpel removal. The histopathological examination was comparable for both methods.


Sujet(s)
Lasers à gaz , Papillome , Tumeurs de la langue , Humains , Mâle , Sujet âgé , Lasers à gaz/usage thérapeutique , Tumeurs de la langue/chirurgie , Tumeurs de la langue/anatomopathologie , Papillome/chirurgie , Papillome/anatomopathologie , Thérapie laser/méthodes , Thérapie laser/instrumentation , Cicatrisation de plaie/physiologie
12.
Photobiomodul Photomed Laser Surg ; 42(5): 339-342, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38776545

RÉSUMÉ

Objective: This study aimed to investigate the effectiveness of prophylactic photobiomodulation (PBM) in reducing postinflammatory hyperpigmentation (PIH) induced by carbon dioxide (CO2) laser resurfacing in a patient with periorbital syringomas. Background: PIH is a common condition characterized by abnormal skin pigmentation after an inflammatory process occurring in up to 20-30% of patients undergoing CO2 laser resurfacing. Methods: The patient was treated with PBM using a pulsed home-use device at 630 nm before and after CO2 laser treatment. The patient was asked to treat the right periorbital area before and after the CO2 laser treatment, which was continued once a day for 2 consecutive weeks. Results: At 12 weeks, PIH was significantly reduced on the treated side compared with the contralateral untreated side (leading to persistent erythema at 6 months). Conclusions: This is the first report of prophylactic treatment of CO2 laser-induced dyschromia using PBM.


Sujet(s)
Hyperpigmentation , Lasers à gaz , Photothérapie de faible intensité , Humains , Lasers à gaz/usage thérapeutique , Hyperpigmentation/étiologie , Hyperpigmentation/radiothérapie , Hyperpigmentation/prévention et contrôle , Femelle , Adulte , Inflammation/radiothérapie
13.
Otolaryngol Head Neck Surg ; 171(1): 172-179, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38639320

RÉSUMÉ

OBJECTIVES: To assess the value of carbon dioxide transoral laser microsurgery (CO2 TOLMS) for early-stage glottic cancer with special regard to involvement of the anterior commissure (AC). STUDY DESIGN: Single-center retrospective cohort study. SETTING: Grade-A tertiary hospital. METHODS: A retrospective analysis of patients with early-stage (Tis-T2) glottic cancer who underwent CO2 TOLMS. All patients had at least 2 years of follow-up. The univariate and multivariate survival analyses were used to identify the risk factors for recurrence and the Kaplan-Meier method was used to analyze OS and DSS rates. RESULTS: A total of 102 patients were included in the study. Eleven patients (10.78%) had recurrence. The univariate analysis showed that the recurrence was associated with the AC classification, T staging, tumor size, and tobacco use (P < .05). However, on multivariate analysis, the AC classification was the only independent risk factor for recurrence (P < .001, HR = 3.179). AC classification were distributed as follows: 59 (57.84%) AC0, 29 (28.43%) AC1, 8 (7.84%) AC2, and 6 (5.88%) AC3, 2-year/5-year OS and DSS rates were progressively reduced in the AC0, AC1, AC2, and AC3 groups (P < .001). At the same T staging, the OS rates incrementally decreased as the level of involvement of the AC became higher (P = .004). CONCLUSION: CO2 TOLMS is an effective treatment for early-stage glottic cancer. AC involvement is an independent risk factors for recurrence and poor prognosis. The AC classification system may be better at grading the prognosis of patients with early-stage glottic cancer and has prognostic value independent of T staging.


Sujet(s)
Glotte , Tumeurs du larynx , Thérapie laser , Microchirurgie , Stadification tumorale , Humains , Tumeurs du larynx/chirurgie , Tumeurs du larynx/anatomopathologie , Tumeurs du larynx/mortalité , Mâle , Glotte/chirurgie , Glotte/anatomopathologie , Études rétrospectives , Femelle , Microchirurgie/méthodes , Adulte d'âge moyen , Thérapie laser/méthodes , Sujet âgé , Résultat thérapeutique , Récidive tumorale locale , Adulte , Lasers à gaz/usage thérapeutique , Sujet âgé de 80 ans ou plus
14.
Clin Otolaryngol ; 49(4): 404-416, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38558499

RÉSUMÉ

BACKGROUND: Laryngeal leukoplakia (LL) is a white lesion with high potential of recurrence and malignant transformation. Currently, CO2 laser has become the primary surgical treatment for LL, and the recurrence and malignant transformation rates after treatment vary widely. OBJECTIVE: We performed a systematic review and meta-analysis dedicated to evaluating the rates of recurrence and malignant transformation of LL lesions treated with CO2 laser and exploring relevant risk factors for recurrence or malignant transformation. METHODS: Literature searches were conducted on ProQuest, PubMed, Web of Science, Ovid Medline, Embase, and Cochrane databases. Some articles identified through hand searching were included. RESULTS: A total of 14 articles and 1462 patients were included in this review. Pooled results showed that the overall recurrence rate was 15%, and the malignant transformation rate was 3%. Subgroup analysis showed that the dysplasia grade was not a significant risk factor for the recurrence and malignant transformation of LL (P > .05). CONCLUSIONS: The results of this systematic review and meta-analysis suggest that the CO2 laser is a safe and effective surgical instrument for the excision of LL, which yields low rates of recurrence and malignant transformation. The risk factors relevant to recurrence or malignant transformation remain unclear and require further investigation.


Sujet(s)
Transformation cellulaire néoplasique , Tumeurs du larynx , Lasers à gaz , Récidive tumorale locale , Humains , Lasers à gaz/usage thérapeutique , Transformation cellulaire néoplasique/anatomopathologie , Récidive tumorale locale/anatomopathologie , Tumeurs du larynx/anatomopathologie , Tumeurs du larynx/chirurgie , Leucoplasie/chirurgie , Leucoplasie/anatomopathologie , Thérapie laser/méthodes , Facteurs de risque
15.
Photobiomodul Photomed Laser Surg ; 42(5): 350-355, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38588575

RÉSUMÉ

Objective: Assessment of different remineralizing pretreatment casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), proanthocyanidin (PA), carbon dioxide laser (CO2), eggshell solution (ES) on the shear bond strength (SBS) of resin composite bonded to remineralized carious-affected dentin (CAD). Materials and methods: Eighty human molars were collected with occlusal caries that extended about halfway into the dentin. Using a water-cooled, low-speed cutting saw, a flat, mid-coronal dentin surface was exposed. CAD was differentiated from healthy dentin. Based on the remineralizing agent used on the CAD surface, the teeth were arbitrarily allocated into five groups (n = 10). Group 1: no remineralizing agent, Group 2: CPP-ACP, Group 3: 6.5% PA solution, Group 4: CO2 laser, and Group 5: ES solution. All samples were bonded to composite and light cured and thermocycled. SBS and failure mode analysis were performed using universal testing and stereomicroscope 40 × . Using SPSS, SBS, and failure mode data were analyzed using analysis of variance and Tukey's honesty significant difference (HSD) test Results: Group 3 (6.5% PA solution; 15.59 ± 1.44 MPa) samples established the maximum bond integrity. Nevertheless, Group 1 (No remineralizing agent; 11.19 ± 1.21 MPa) exhibited the minimum outcome of bond strength. Intergroup comparison analysis showed that Group 1 (No remineralizing agent), Group 2 (CPP-ACP), and Group 4 (CO2 laser) established comparable values of bond strength (p > 0.05). Likewise, Group 3 (6.5% PA solution) and Group 5 (EA solution) also revealed equivalent bond integrity (p > 0.05). Conclusions: PA and ES are considered potential remineralizing agents used for caries-affected dentin surfaces in improving bond integrity to composite resin. However, further studies are advocated to extrapolate the findings of this study.


Sujet(s)
Caséines , Caries dentaires , Lasers à gaz , Proanthocyanidines , Reminéralisation des dents , Humains , Proanthocyanidines/pharmacologie , Reminéralisation des dents/méthodes , Lasers à gaz/usage thérapeutique , Caries dentaires/thérapie , Dentine/effets des radiations , Résines composites/composition chimique , Collage dentaire , Résistance au cisaillement , Techniques in vitro , Restaurations dentaires permanentes , Molaire
16.
Lasers Med Sci ; 39(1): 114, 2024 Apr 25.
Article de Anglais | MEDLINE | ID: mdl-38662131

RÉSUMÉ

Nasal mucosa tumors are an uncommon process and very dificult to work on with surgery. Radiotherapy associated or not with chemotherapy is the standard method to treat the disease. However, its access it is in the majority of the case not possible, making the surgery the best choice to try to achieve the patient's control. The anatomy of the region makes the complete surgical resection very difficult to achieve using the common and conventional blade scalpel surgery. The study features the advantages of using a CO2 laser to perform nasal mucosa carcinoma surgery in 6 dogs (N = 6). For the work we used an Aesculigth CO2 surgical laser model -Vetscalpel®, with the settings of 12Watts in a Superpulse mode, and a 0.25-0.4 mm focus to dissect the nasal mucosa, and a 1.5 mm focus for vaporization of the area. All the masses were histopathologically characterized as squamous cells carcinoma. The CO2 surgical laser allow us to work in a bloodless region promoting a more accurate dissection of the nasal mucosa sparing therefore the underlying and adjacent tissues and being less invasive. Also, it was possible to do the vaporization of the entire surgical area interviened. None of the patients presented relapse of clinical signs. Only 2 individuals were alive at the end of the study, presenting a survival rate of 420 and 514 days, which is in the same line of literature results of the treatment with radiotherapy combined with chemotherapy wich shows a median of 474-580 days. The study demonstrates successful outcomes with CO2 laser surgery in treating nasal mucosa SCC in dogs, with patients experiencing improved survival rates compared to traditional treatment methods. This highlights the efficacy and potential of CO2 laser surgery as a valuable tool in managing aggressive nasal tumors in veterinary oncology.


Sujet(s)
Carcinome épidermoïde , Lasers à gaz , Muqueuse nasale , Tumeurs du nez , Chiens , Animaux , Lasers à gaz/usage thérapeutique , Carcinome épidermoïde/chirurgie , Carcinome épidermoïde/anatomopathologie , Études prospectives , Muqueuse nasale/chirurgie , Muqueuse nasale/anatomopathologie , Tumeurs du nez/chirurgie , Tumeurs du nez/anatomopathologie , Tumeurs du nez/radiothérapie , Maladies des chiens/chirurgie , Mâle , Femelle , Thérapie laser/méthodes , Thérapie laser/instrumentation
17.
Lasers Med Sci ; 39(1): 117, 2024 Apr 28.
Article de Anglais | MEDLINE | ID: mdl-38678503

RÉSUMÉ

The skin contraction phenomenon occurs due to the energy emitted by the surgical CO2 LASER affecting the collagen architecture and intracellular water content in tissues. The study aimed to assess how gender, age, breed, body-weight, CO2 LASER emission mode, and potency influence skin contraction following the incision. The study involved 80 dogs (N = 80) of both genders, multiple breeds, undergoing major surgery with CO2 LASER. Subjects were grouped based on LASER potency (12 or 15 Watts) and emission mode (Superpulse-SP or Continuous-CT): GSP12, GSP15, GCT12, and GCT15. A 10 mm incision was performed using the surgical CO2 LASER beam, consistently employing a focal point of 0.4 mm, positioned at a distance of 1 mm from the skin surface, and always maintained perpendicular to it, and resulting lengths measured with a digital caliper. Results were considered significant for p-value < 0.05. GSP12 showed minimal contraction, while GCT15 exhibited the most significant. Male subjects in GCT12, GCT15, and GSP12 experienced less contraction than females. Purebred dogs had greater contraction than mixed breeds. GSP12 individuals showed age-related contraction decrease (p < 0.01), with skin contracting by 0.09 mm per year. Weight and skin contraction trended towards significance (p = 0.06), with a 0.02 mm increase per unit weight. For a constant power of 12 W, the analysis of the relationship between the emission mode of the LASER beam and the final skin contraction (GSP12 vs. GCT12) revealed statistically significant differences (p < 0.01). This study suggests that the use of the Continuous mode of LASER emission, regardless of the power used, is associated with a higher level of final skin contraction. TRIAL REGISTRATION NUMBER AND DATE OF REGISTRATION FOR PROSPECTIVELY REGISTERED TRIALS: Project approval registration number by the Research and Teaching Ethics Committee (CEIE),Faculty of Veterinary Medicine-University of Lisbon (FMV_ULisboa), Lisboa-Portugal, N/Refª 015/2022.


Sujet(s)
Lasers à gaz , Peau , Chiens , Animaux , Lasers à gaz/usage thérapeutique , Mâle , Femelle , Peau/effets des radiations , Phénomènes physiologiques de la peau
18.
Rev. argent. cir. plást ; 30(1): 54-59, 20240000. fig, tab
Article de Espagnol | LILACS, BINACIS | ID: biblio-1551393

RÉSUMÉ

El síndrome genitourinario es una entidad hoy en día cada vez más frecuente en la mujer posmenopáusica, con signos y síntomas muy característicos que llevan a la pérdida de calidad de vida de las pacientes, generados por la disminución de estrógenos. Su diagnóstico se realiza mediante una buena historia clínica, exámenes hormonales, estudios urodinámicos y de pH vaginal. Su clínica varía desde sequedad vaginal, atrofia de la misma, vaginitis a repetición, pérdida de orina al esfuerzo, nicturia y dispareunia. A los largo de los años se han protocolizado diferentes tratamientos como reemplazos hormonales, lubricantes y cirugías invasivas vaginales. Pero en los últimos años ha aparecido una nueva terapéutica de láser CO2 fraccionado. Materiales y método. Se realizó un estudio retrospectivo de seis años de evolución, entre los años 2017 y 2023, con más de 300 pacientes tratadas con tecnología láser CO2 fraccionado, con criterios de inclusión y exclusión, protocolizando 3 sesiones cada 30 días y controles hasta los 6 meses. Resultados. Para evaluar los resultados se diseñó una encuentra de satisfacción de 5 puntos, la cual fue presentada luego de cada sesión, encontrando un alto grado de satisfacción en la mejoría clínica a medida que transcurrían las sesiones, con un muy bajo índice de complicaciones. También biopsias con mejorías histológicas que demuestran resultados. Discusión. La aplicación de esta nueva tecnología láser nos abre una posibilidad terapéutica segura, rápida y efectiva para mejorar la sintomatología y calidad de vida de nuestras pacientes con síndrome genitourinario, sumando una nueva terapéutica a todo el arsenal de tratamientos médico-quirúrgicos disponibles a la fecha. Conclusiones. El síndrome genitourinario es una entidad prácticamente inevitable, con síntomas desde leves a graves, que afecta la calidad de vida personal, sexual y social. Los tratamientos hasta la fecha hormonales, tópicos o quirúrgicos han dado mediocres resultados sin estar exentos de complicaciones, por lo que la aparición de la tecnología láser CO2 fraccionada nos ha dado el plus necesario para aportar un tratamiento seguro, eficaz, con mínimas complicaciones y una curva de aprendizaje pequeña


Genitourinary syndrome is an increasingly frequent entity in postmenopausal women today, with very characteristic signs and symptoms that lead to a loss of quality of life in patients, generated by estrogen depletion, whose diagnosis is made through a good clinical history, hormonal tests, urodynamic and vaginal pH studies. Its symptoms vary from vaginal dryness, vaginal atrophy, repeated vaginitis, loss of urine on exertion, nocturia and dyspareunia. Over the years, different treatments have been protocolized, such as hormone replacements, lubricants, and invasive vaginal surgeries. But in recent years a new fractionated CO2 laser therapy has appeared. Materials and method. A retrospective study of six years of evolution was carried out, between the years 2017 and 2023, with more than 300 patients treated with fractionated CO2 laser technology, with inclusion and exclusion criteria, protocolizing 3 sessions every 30 days and controls until the 6 months. Results. To evaluate the results, a 5-point satisfaction score was designed, which was presented after each session, finding a high degree of satisfaction in the clinical improvement as the sessions progressed with a very low indication of complications. Also biopsies with histological improvements that demonstrate results. Discussion. The application of this new laser technology opens up a safe, fast and effective therapeutic possibility to improve the symptoms and quality of life of our patients with genitourinary syndrome, adding a new therapeutic option to the arsenal of medical-surgical treatments available to date. Conclusions. Genitourinary syndrome is a practically inevitable entity, with symptoms ranging from mild to severe, affecting the quality of personal, sexual and social life. The hormonal, topical or surgical treatments to date have given mediocre results, not being free of complications, so the appearance of fractionated CO2 laser technology has given us the necessary extra to provide a safe, effective treatment, with minimal complications. and a small learning curve.


Sujet(s)
Humains , Femelle , Syndrome , Appareil urogénital/physiopathologie , Études de suivi , Lasers à gaz/usage thérapeutique , Vaginite atrophique/thérapie
20.
Acta Otolaryngol ; 144(2): 118-122, 2024 Feb.
Article de Anglais | MEDLINE | ID: mdl-38546378

RÉSUMÉ

BACKGROUND: Laser fenestration in stapedotomy has thermal effect to the vestibule. AIMS/OBJECTIVES: To evaluate the role of energy density (fluence) in the severity of postoperative vestibular symptoms. MATERIALS AND METHODS: The retrospective chart-review study included 84 patients with otosclerosis that underwent primary laser stapedotomy. Surgical outcomes, including nystagmus, and subjective vestibular symptoms during one-month follow-up, were compared between potassium titanyl phosphate (KTP) and CO2 laser. According to this study and literature, we assessed the relationship between laser parameters and the incidence of persistent vestibular symptoms lasting more than one week after surgery. RESULTS: The KTP and CO2 laser group included 48 and 36 patients, respectively. Fluence was different between the KTP (637 J/cm2) and CO2 (141 J/cm2) laser (p < .001). The KTP group showed gradual decrease in dizziness during one-month observation period, while the CO2 group exhibited a steep recovery curve in the first postoperative week (9 and 4 d of duration, respectively). The incidence of persistent vestibular symptoms was correlated with both fluence (r = 0.80, p = .01) and spot size (r = -0.74, p = .01). CONCLUSIONS AND SIGNIFICANCE: Appropriate setting of parameters with lower fluence is desirable for the efficiency and safety of laser stapedotomy.Abbreviations: ABG: air-bone gap; SD: standard deviation.


Sujet(s)
Sensation vertigineuse , Lasers à gaz , Otosclérose , Chirurgie de l'étrier , Humains , Chirurgie de l'étrier/méthodes , Chirurgie de l'étrier/effets indésirables , Mâle , Femelle , Études rétrospectives , Adulte d'âge moyen , Otosclérose/chirurgie , Adulte , Sensation vertigineuse/étiologie , Lasers à gaz/usage thérapeutique , Lasers à solide/usage thérapeutique , Complications postopératoires/étiologie , Complications postopératoires/épidémiologie , Thérapie laser/effets indésirables , Thérapie laser/méthodes , Sujet âgé
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...